NTT DATA Launches Agentic AI Services for Hyperscaler AI Technologies
NTT DATA, a global leader in digital business and technology services, today announced the launch of its Agentic AI Services for Hyperscaler AI Technologies. This transformative suite of services helps organizations easily adopt, build, manage and scale AI-powered agents to improve efficiencies, unlock innovation and enhance employee and customer experiences, maximizing returns on AI investments.
This unique suite of services addresses the growing demand for agentic AI solutions that offer personalized experiences. This news builds on NTT DATA’s recently announced Smart AI Agent™, enabling enterprises to integrate AI-driven automation across business functions. Unlike traditional automation, Agentic AI understands user needs, engages naturally and handles complex interactions, empowering organizations to confidently scale their AI capabilities while ensuring optimization and success.
NTT DATA’sAgentic AI Services for Hyperscaler AI Technologies offers the industry’s most comprehensive suite of services for AI. These services support every stage of an organization’s agentic AI journey with cloud providers – from advisory and building AI agents to implementation, connectivity and ongoing managed services.
Applicable across all industries including manufacturing, banking and healthcare, these services help organizations maximize AI investments and responsibly innovate while ensuring ongoing optimization and success. Available in over 20 languages across every major market, NTT DATA ensures seamless global adoption.
By integrating its agentic AI with generative AI, including large and small language models, these AI agents can perform tasks more rapidly, accurately and efficiently with fewer errors. NTT DATA also helps to ensure clients that once AI agents are deployed, they remain secure, up-to-date and continuously improved. By connecting AI agents to hyperscaler data centers, NTT DATA helps to enable more personalized, natural interactions, making AI-driven services more intuitive and effective.
Meeting the demand for scalable AI solutions
Enterprise AI investments are accelerating. According to Gartner®, “by 2028, the market for artificial intelligence services will reach $609 billion with a five-year annual growth rate of 21.4% in constant U.S. dollars.” Additionally Gartner also states that “By 2028, “33% of enterprise software applications will include agentic AI, up from less than 1% in 2024, enabling 15% of day-to-day work decisions to be made autonomously.”
NTT DATA’s own Global GenAI Report reflects this trend, showing organizations are increasingly prioritizing agentic AI for back-office and workflow optimization in 2025. The report also found that 96% of CIOs and CTOs prefer cloud-based solution methods.
“Agentic AI will revolutionize business operations and NTT DATA is at the forefront of this transformation,” said Charlie Li, Global Head of Cloud & Security, NTT DATA, Inc. “As the first global provider to offer comprehensive agentic AI services with a focus on AI agent management, we are empowering organizations to invest in AI agents with confidence– unlocking unprecedented efficiency and innovation while enhancing the experiences they provide to their employees and customers.”
Flexible agentic AI services
NTT DATA’s Agentic AI Services for Hyperscaler AI Technologies are available in flexible packages, allowing organizations to scale AI adoption with industry leading support that can easily align to clients’ budgets, resources and timeframes.
- Advisory services: Guidance on adopting and optimizing agentic AI solutions, including planning, design, GenAI, business process optimization and automation tailored to specific business needs.
- Implementation services: AI agent configuration, integration and deployment focused on security, compliance and performance optimization with complementary change management options.
- Ongoing AI management services: Continuous monitoring, troubleshooting, data governance and detailed reporting and analytics.
- Connectivity: Seamless connectivity across all channels using NTT DATA’s cloud-native global connectivity services for voice, chat and mobile integration, ensuring consistent monitoring and compliance with local regulations.
Advanced expertise to accelerate innovation with hyperscalers
NTT DATA is uniquely positioned to deliver innovative and comprehensive capabilities and services as a systems integrator, managed services provider and carrier. This allows for faster and more efficient deployment of AI agents anchored in our commitment to responsible AI.
NTT DATA is launching its Agentic AI Services for Hyperscaler AI Technologies with an initial focus on Microsoft platforms. As the leading Microsoft Cloud Voice partner and a top provider of Copilot for Microsoft 365, NTT DATA is well-positioned to help enterprises integrate AI agents into their daily operations.
By leveraging cutting-edge tools such as Azure AI Foundry and Copilot Studio, NTT DATA agents are equipped to deliver even more innovative and effective solutions to clients.
“AI-powered agents are transforming how businesses operate, and we are excited to collaborate with NTT DATA to help organizations embrace this new era of AI-powered innovation,” said Maziar Zolghadr, General Manager Global Communications Partners, Microsoft. “Combining Microsoft’s AI technologies with NTT DATA’s expertise in AI agent building, deployment and management we are empowering enterprises to create more intelligent experiences for their employees and clients.”
Real-world applications across industries
NTT DATA’s Agentic AI Services for Hyperscaler AI Technologies offer solutions across functions and use cases, providing easy-to-implement solutions such as:
- Customer service: Automating query resolution and enabling self-service to reduce wait times.
- Billing and scheduling: Streamlining repetitive tasks to save time and improve operational efficiency.
- Training and onboarding: Accelerating employee onboarding and skills development.
- Logistics and risk management: Enhancing processes like fraud protection and data analysis for insight-driven decisions.
- HR and sales assistants: Offering voice, chat and messaging options for improved communication and task management.
- Workflow automation: Smart assistants optimize task routing process management.
Future growth and expansion
With today’s launch, NTT DATA builds on its established GenAI capabilities, further strengthening its position as a leader in AI-driven enterprise solutions.
NTT DATA’s Agentic AI Services for Hyperscaler AI Technologies are designed to work with a wide range of AI platforms and will continue to expand to support new technologies. These services are integral to NTT DATA’s broader managed services portfolio across cloud, networking and cybersecurity.
NTT DATA Smart AI Agent offers a comprehensive end-to-end and full-stack solution that includes AI agents consulting, platforms, third-party integrations and managed services to transform business processes across industries. By streamlining operations and enhancing efficiency, Smart AI AgentTM empower businesses to rapidly evaluate and deploy generative AI applications, optimize workflows and drive greater productivity.
About NTT DATA
NTT DATA is a $30+ billion trusted global innovator of business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize and transform for long-term success. As a Global Top Employer, we have diverse experts in more than 50 countries and a robust partner ecosystem of established and start-up companies. Our services include business and technology consulting, data and artificial intelligence, industry solutions, as well as the development, implementation and management of applications, infrastructure and connectivity. We are also one of the leading providers of digital and AI infrastructure in the world. NTT DATA is part of NTT Group, which invests over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future.
Visit us at nttdata.com.
*Gartner Article, Intelligent Agents in AI Really Can Work Alone. Here’s How. By Tom Coshow | October 1, 2024
*GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
* Smart AI Agent is a trademark of NTT DATA Group Corporation.
* Other product, company and organization names are trademarks or registered trademarks of the respective companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320628624/en/
Contacts
Lori Bosio
External Communications, NTT DATA, Inc.
lori.bosio@global.ntt
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AlbaCore Launches its Senior Direct Lending Strategy, with Commitments from ADIA and Mitsubishi UFJ Trust and Banking Corporation27.3.2025 08:00:00 CET | Press Release
European credit specialist AlbaCore Capital Group (“AlbaCore”) today announces the launch of a new Senior Direct Lending Strategy (“the Strategy”), having secured anchor investments from a wholly owned subsidiary of the Abu Dhabi Investment Authority (“ADIA”) and Mitsubishi UFJ Trust and Banking Corporation (the “Trust Bank”). AlbaCore has successfully completed its first close, bringing together an expected $1.8 billion in investable capital. With the launch of the Strategy, AlbaCore is well positioned to take advantage of the growing opportunity set to finance loans, further expanding its market presence and delivering enhanced value to clients globally. “Securing commitments from ADIA and the Trust Bank for the first vintage of our Senior Direct Lending Strategy is a testament to the attractiveness of the opportunity set in the market and how well positioned AlbaCore is to take advantage of it,” said David Allen, Managing Partner and Chief Investment Officer at AlbaCore. The Strateg
Nederlandse Innovatie Maatschappij (NIM) Leads H2ESTIA Project: The Future of Emission-Free Cargo Transport27.3.2025 07:00:00 CET | Press Release
The maritime industry is taking a large step toward sustainability with the launch of the H2ESTIA Project, a groundbreaking initiative to develop the world’s first zero-emission general cargo ship powered by liquid hydrogen. Led by the Dutch Innovation Company (NIM – www.nim-bv.nl ) and supported by the Dutch Ministry of Infrastructure and Water Management, this initiative is a key pillar of the Maritime Masterplan, setting a new standard for decarbonizing European maritime logistics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250326530510/en/ Concept design of the zero-emission hydrogen powered bulk carrier The project focuses on designing, constructing, and demonstrating a hydrogen-powered cargo vessel that will operate in the North Sea and beyond. Managed by Van Dam Shipping, the ship is designed to transport bulk goods, eliminating harmful emissions and redefining the future of sustainable shipping. At the heart of t
IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale27.3.2025 07:00:00 CET | Press Release
IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio’s production will use IFF’s Designed Enzymatic Biomaterial™ (DEB) platform technology, integrated at the IFF biorefinery in Kotka, Finland. "Our partnership with Kemira has reached a significant milestone, enabling us to scale the production of groundbreaking biobased materials to meet the large and growing demand for high-performing and sustainable alternatives to fossil-derived polymers," said Erik Fyrwald, IFF CEO. "IFF’s DEB technology not only guarantees superior purity and consistency compared to traditional biopolymers but also en
Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis27.3.2025 07:00:00 CET | Press Release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatment that modify the natural history of knee osteoarthritis, announces that it has been authorized by Health Canada to launch the Phase 2a INFLAM MOTION “Proof-of-Concept” study for 4P004 in patients with knee osteoarthritis. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250326675460/en/ Health Canada Authorizes 4Moving Biotech to Launch Phase 2a INFLAM MOTION Clinical Trial for Knee Osteoarthritis The INFLAM MOTION Study is a Phase 2a multicenter, randomized, double-blind, placebo-controlled trial conducted in the EU, US, and Canada, including three sites in Canada. It will enroll 129 patients to evaluate, for the first time, the efficacy of 4P004 in individuals with knee osteoarthritis. 4P004 is a GLP-1 analog, tailored for intra-articular use in knee osteoarthritis. It was developed to exploit the analgesic, anti-inflammatory, anti
Curatis: Sales growth of 30% in distribution - plus significant expansion of patient target group for lead project C-PTBE-0127.3.2025 07:00:00 CET | Press Release
Curatis Holding AG (SIX:CURN, ‘Curatis’) reports business revenues of CHF 6.9m for 2024, whereby Curatis AG is only included for 8 months. Curatis AG was able to increase sales in the distribution business by 30% per cent to CHF 9.5m in the full year 2024 compared to 2023. Further key statements: Curatis is increasing the estimate for the number of patients addressed in the lead project C-PTBE-01 by a factor of 20. The reason for this is that Curatis can apply for a biologics licence for C-PTBE-01, which grants 12 years of market protection in the USA. This suggests an expansion of the indications, namely from PTBE in diffuse midline glioma (DMG) in children to PTBE in other primary and metastatic brain tumours in children and adults. A meeting with the US Food and Drug Administration (FDA) to discuss a potential pivotal Phase III trial for C-PTBE-01 is in preparation and is targeted for Q2. The strong cash position of CHF 3m at the end of the year combined with the positive, growing c
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom